Company Filing History:
Years Active: 2013-2014
Title: Mogens Peter Cherly Nielsen: Innovator in GABA Receptor Modulation
Introduction
Mogens Peter Cherly Nielsen is a notable inventor based in Roskilde, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate GABA receptors. His work has implications for treating various conditions, including anxiety and convulsions.
Latest Patents
Nielsen holds 2 patents that focus on novel compounds with anxiolytic, anticonvulsant, sedative-hypnotic, and myorelaxant properties. His latest patents include innovative compounds of the general formula (I), which serve as GABA receptor modulators. Additionally, he has developed GABA/BzR ligands of general formulas (I), (II), and (III), which are designed to treat similar conditions in mammals, including humans.
Career Highlights
Mogens Peter Cherly Nielsen is associated with Innovationspatent Sverige AB, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from various neurological conditions.
Collaborations
Nielsen has collaborated with notable colleagues, including Tommy Liljefors and Jakob Nilsson, to enhance the scope and impact of his research. Their combined expertise contributes to the innovative solutions being developed in the field of pharmacology.
Conclusion
Mogens Peter Cherly Nielsen is a distinguished inventor whose work in GABA receptor modulation is paving the way for new treatments in pharmacology. His contributions are vital for advancing medical science and improving patient care.